Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04042324 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
A Phase 1 study, sponsored by Rockwell Medical Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT04042324 is a Phase 1 study that has completed, run by Rockwell Medical Technologies. The registered enrollment target is 12 participants.
The verdict
NCT04042324, a Phase 1 study, has completed, sponsored by Rockwell Medical Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will investigate the effect of co-administration of Triferic and heparin on the ability to maintain circuit anti-coagulation and iron delivery when compared to control conditions when each treatment is administered via separate routes.
Interventions
- DRUG Heparin
- DRUG Triferic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2020-01-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04042324
The ClinicalTrials.gov registry entry for NCT04042324 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockwell Medical Technologies, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Heparin is the first listed.
NCT04042324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04042324 about?
NCT04042324 is a clinical study titled "A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients". This study will investigate the effect of co-administration of Triferic and heparin on the ability to maintain circuit anti-coagulation and iron delivery when compared to control conditions when each treatment is administered via separate routes.
What is the current status of trial NCT04042324?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2019-09-30. Estimated completion is 2020-01-16.
What interventions are being tested in trial NCT04042324?
The interventions under investigation include: Heparin (DRUG), Triferic (DRUG).
Who is sponsoring clinical trial NCT04042324?
This trial is sponsored by Rockwell Medical Technologies, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.